|
Recent Developments in Drug Therapy for Aplastic Anemia
|
Sep 2014
|
Ann Pharmacother
|
aplastic anemia
|
|
Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
|
Sep 2014
|
Ann Oncol
|
myelodysplastic syndromes (MDS)
|
|
Short- and long-term benefits of lenalidomide treatment in patients with lower-risk del(5q) myelodysplastic syndromes
|
Oct 2015
|
Ann Oncol
|
myelodysplastic syndromes (MDS)
|
|
Cytogenetics in benzene-associated myelodysplastic syndromes and acute myeloid leukemia: new insights into a disease continuum
|
Mar 2014
|
Ann N Y Acad Sci
|
myelodysplastic syndromes (MDS)
|
|
Myelodysplastic syndromes in the United States: an update for clinicians
|
Apr 2014
|
Ann Med.
|
myelodysplastic syndromes (MDS)
|
|
A novel marker for screening paroxysmal nocturnal hemoglobinuria using routine complete blood count and cell population data
|
Jan 2015
|
Ann Lab Med
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome.
|
Apr 2012
|
Ann Hematol.
|
aplastic anemia
|
|
The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes.
|
May 2013
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
|
Application of the revised International Prognostic Scoring System for myelodysplastic syndromes in Argentinean patients
|
Jul 2013
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
|
Asymptomatic cerebral bleeds in patients with aplastic anemia.
|
Mar 2012
|
Ann Hematol
|
aplastic anemia
|
